Vulnerability · CVE-2023-20963
Android Framework Privilege Escalation Vulnerability
Published Mar 6, 2023 · catalog updated Jun 16, 2026 · Android Framework
Patch now
CVE-2023-20963 is in the CISA known-exploited catalog, due May 4, 2023. Confirm Android Framework against the vendor advisory and apply that fix. The CVSS score does not change the priority.
- Severity
- High7.8
- Known exploitation
- CISA KEV and VulnCheck KEV
- EPSS
- 1.47%
- Remediation
- Remediation guidance
- Affected products
- cpe google/android · vendor Android Framework
In WorkSource, there is a possible parcel mismatch. This could lead to local escalation of privilege with no additional execution privileges needed. User interaction is not needed for exploitation.Product: AndroidVersions: Android-11 Android-12 Android-12L Android-13Android ID: A-220302519
Are you affected?
Enter the version you run. The result uses only the ranges stored on this record.
The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.
- cpe google/android11.0
- cpe google/android12.0
- cpe google/android12.1
- cpe google/android13.0
- vendor Android Frameworkversion unspecified
How to fix CVE-2023-20963
Recommended remediation
Apply updates per vendor instructions. CISA due date May 4, 2023.
Official advisories
What to do
Three questions, each answered from this record only. Confirm the vendor advisory before you patch.
Should you patch?
CVE-2023-20963 is in the CISA known-exploited catalog, due May 4, 2023. Confirm Android Framework against the vendor advisory and apply that fix. The CVSS score does not change the priority.
Which versions are affected?
Compare what you have installed with 11.0, 12.0, 12.1, 13.0. Apply updates per vendor instructions.
What should an analyst verify?
CWE-295: Improper Certificate Validation. EPSS 1.47%. The CISA KEV listing is the exploitation evidence. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.
Code
The project this record applies to. Exploit listings stay in References.
No public source repository is identified for this product.
Timeline
Detection, updates, and resolution for this record.
Mar 24, 2023 · Catalog
Detected
In WorkSource, there is a possible parcel mismatch. This could lead to local escalation of privilege with no additional execution privileges needed. User interaction is not needed for exploitation.Product: AndroidVersions: Android-11 Android-12 Android-12L Android-13Android ID: A-220302519
Apr 13, 2023 · CISA KEV
Known exploited
Apply updates per vendor instructions.
May 4, 2023 · CISA KEV
Remediation due
Apply updates per vendor instructions.
Jun 16, 2026 · Catalog
Updated
In WorkSource, there is a possible parcel mismatch. This could lead to local escalation of privilege with no additional execution privileges needed. User interaction is not needed for exploitation.Product: AndroidVersions: Android-11 Android-12 Android-12L Android-13Android ID: A-220302519
Sources
- CISA KEVConfirmed exploitationCVE-2023-20963
Android Framework contains an unspecified vulnerability that allows for privilege escalation after updating an app to a higher Target SDK with no additional execution privileges needed.
cisa.gov - CVE.orgVulnerability recordCVE-2023-20963
Official CVE identifier
cve.org - FIRST EPSSExploitation probabilityCVE-2023-20963
30-day exploitation probability 1.5%
first.org - NIST NVDVulnerability recordCVE-2023-20963
In WorkSource, there is a possible parcel mismatch. This could lead to local escalation of privilege with no additional execution privileges needed. User interaction is not needed for exploitation.Product: AndroidVersions: Android-11 Android-12 Android-12L Android-13Android ID: A
nvd.nist.gov - VulnCheck KEVConfirmed exploitationCVE-2023-20963
Android Framework contains an unspecified vulnerability that allows for privilege escalation after updating an app to a higher Target SDK with no additional execution privileges needed.
vulncheck.com
References
Freshness
Last verified in this catalog Oct 17, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.